開普檢測(003008.SZ):目前公司傳統業務並未出現萎縮情況,相關業務正在恢復增長
格隆匯5月19日丨開普檢測(003008.SZ)於2023年5月18日參與河南轄區上市公司2023年投資者網上集體接待日活動,就“請問公司今年在新能源電力設備檢測業務方面是否有大幅增長?公司傳統業務是否在不斷萎縮?”,公司表示,目前國家“雙碳”戰略支持新能源持續建設發展,新能源控制設備(如光伏逆變器、功率控制、儲能系統等)市場不斷髮展,從2022年和今年一季度業績情況看,公司新能源控制設備檢測業務均呈現同比上升趨勢。其中,2022年同比增長32.54%。目前,公司傳統業務並未出現萎縮情況,公司2022年年報、2023年一季報均顯示相關業務正在恢復增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.